The Chemical Synthesis of Site-Specifically Modified Proteins Via Diselenide-Selenoester Ligation
© 2021. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature..
Peptide ligation techniques enable the controlled chemical synthesis of native and engineered proteins, including examples that display site-specific post-translational modifications (PTMs) and non-proteinogenic functionality. Diselenide-selenoester ligation (DSL) is a recent addition to the synthetic methodology that offers several advantages over existing strategies. The standard DSL reaction involves the additive-free ligation of a peptide carrying an N-terminal selenocysteine (Sec) residue with a fragment bearing a C-terminal selenoester. This operationally simple ligation proceeds rapidly at sterically hindered junctions and is efficient across a broad pH range. The incorporation of deselenization and oxidative deselenization techniques into the DSL protocol enables conversion of the Sec residue at the ligation site to alanine (Ala) and serine (Ser), respectively, thus enhancing the scope and versatility of the method. In this chapter, we describe the application of DSL to the one-pot chemical synthesis of proteins via both two-component and three-component ligation pathways.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:2355 |
---|---|
Enthalten in: |
Methods in molecular biology (Clifton, N.J.) - 2355(2021) vom: 12., Seite 231-251 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Griffiths, Rhys C [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 11.01.2022 Date Revised 11.01.2022 published: Print Citation Status MEDLINE |
---|
doi: |
10.1007/978-1-0716-1617-8_18 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM329307452 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM329307452 | ||
003 | DE-627 | ||
005 | 20231225204830.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/978-1-0716-1617-8_18 |2 doi | |
028 | 5 | 2 | |a pubmed24n1097.xml |
035 | |a (DE-627)NLM329307452 | ||
035 | |a (NLM)34386962 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Griffiths, Rhys C |e verfasserin |4 aut | |
245 | 1 | 4 | |a The Chemical Synthesis of Site-Specifically Modified Proteins Via Diselenide-Selenoester Ligation |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.01.2022 | ||
500 | |a Date Revised 11.01.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2021. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature. | ||
520 | |a Peptide ligation techniques enable the controlled chemical synthesis of native and engineered proteins, including examples that display site-specific post-translational modifications (PTMs) and non-proteinogenic functionality. Diselenide-selenoester ligation (DSL) is a recent addition to the synthetic methodology that offers several advantages over existing strategies. The standard DSL reaction involves the additive-free ligation of a peptide carrying an N-terminal selenocysteine (Sec) residue with a fragment bearing a C-terminal selenoester. This operationally simple ligation proceeds rapidly at sterically hindered junctions and is efficient across a broad pH range. The incorporation of deselenization and oxidative deselenization techniques into the DSL protocol enables conversion of the Sec residue at the ligation site to alanine (Ala) and serine (Ser), respectively, thus enhancing the scope and versatility of the method. In this chapter, we describe the application of DSL to the one-pot chemical synthesis of proteins via both two-component and three-component ligation pathways | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Chemical protein synthesis | |
650 | 4 | |a Chemoselective | |
650 | 4 | |a Deselenization | |
650 | 4 | |a Diselenide-selenoester ligation | |
650 | 4 | |a Native chemical ligation | |
650 | 4 | |a Peptide | |
650 | 4 | |a Selenocysteine | |
650 | 4 | |a Selenoester | |
650 | 7 | |a Peptides |2 NLM | |
650 | 7 | |a Proteins |2 NLM | |
650 | 7 | |a Selenocysteine |2 NLM | |
650 | 7 | |a 0CH9049VIS |2 NLM | |
650 | 7 | |a Serine |2 NLM | |
650 | 7 | |a 452VLY9402 |2 NLM | |
700 | 1 | |a Mitchell, Nicholas J |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Methods in molecular biology (Clifton, N.J.) |d 1984 |g 2355(2021) vom: 12., Seite 231-251 |w (DE-627)NLM074849794 |x 1940-6029 |7 nnns |
773 | 1 | 8 | |g volume:2355 |g year:2021 |g day:12 |g pages:231-251 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/978-1-0716-1617-8_18 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 2355 |j 2021 |b 12 |h 231-251 |